Southwell Gavin 4
4 · Health Insurance Innovations, Inc. · Filed Feb 5, 2019
Insider Transaction Report
Form 4
Southwell Gavin
President and CEO
Transactions
- Sale
Class A Common Stock
2019-02-04$40.31/sh−65,899$2,656,343→ 543,824 total - Sale
Class A Common Stock
2019-04-05$40.03/sh−7,647$306,090→ 536,177 total - Sale
Class A Common Stock
2019-02-01$40.02/sh−6,150$246,113→ 609,723 total
Holdings
- 20,000
Stock Appreciation Rights
Exercise: $6.10Exp: 2023-04-26→ Class A Common Stock (20,000 underlying) - 33,333
Stock Appreciation Rights
Exercise: $5.96Exp: 2023-09-06→ Class A Common Stock (33,333 underlying) - 100,000
Stock Appreciation Rights
Exercise: $10.30Exp: 2023-11-15→ Class A Common Stock (100,000 underlying)
Footnotes (6)
- [F1]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $41.58, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.08, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]These stock-settled stock appreciation rights were granted under the Plan and vest 50% on the first anniversary of grant date and 50% on the second anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
- [F5]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first anniversary of grant date, 25% on the second anniversary of grant date, and 50% on the third anniversary of grant date, subject to the terms of the Plan and an award agreement under the Plan.
- [F6]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on each of the first four anniversaries of the date of grant, subject to the terms of the Plan and an award agreement under the Plan.